All Categories
Refine Search
CCR2-RA-[R]
Novel, potent, acidic CCR2 receptor antagonist, more active enantiomer of CRR2-RA (AOB4939)
CCS-1477
Novel potent, selective and orally bioavailable inhibitor of the Bromodomain of p300 and CBP,
CDBT
Novel tubulin and HSP90 dual inhibitor, causing the destabilization of microtubules and degradation of HSP90 client proteins CRAF-1 and ERBB2, resulting in cell cycle arrest at the G2/M phase and apoptosis
